
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Mélanie Drolet, Élodie Bénard, Norma Pérez, et al.
The Lancet (2019) Vol. 394, Iss. 10197, pp. 497-509
Open Access | Times Cited: 1046
Mélanie Drolet, Élodie Bénard, Norma Pérez, et al.
The Lancet (2019) Vol. 394, Iss. 10197, pp. 497-509
Open Access | Times Cited: 1046
Showing 1-25 of 1046 citing articles:
Cancer statistics, 2020
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 1, pp. 7-30
Open Access | Times Cited: 18746
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 1, pp. 7-30
Open Access | Times Cited: 18746
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn, Elisabete Weiderpass, Laia Bruni, et al.
The Lancet Global Health (2019) Vol. 8, Iss. 2, pp. e191-e203
Open Access | Times Cited: 3352
Marc Arbyn, Elisabete Weiderpass, Laia Bruni, et al.
The Lancet Global Health (2019) Vol. 8, Iss. 2, pp. e191-e203
Open Access | Times Cited: 3352
Sexually Transmitted Infections Treatment Guidelines, 2021
Kimberly Workowski, Laura H. Bachmann, Philip A. Chan, et al.
MMWR Recommendations and Reports (2021) Vol. 70, Iss. 4, pp. 1-187
Open Access | Times Cited: 1589
Kimberly Workowski, Laura H. Bachmann, Philip A. Chan, et al.
MMWR Recommendations and Reports (2021) Vol. 70, Iss. 4, pp. 1-187
Open Access | Times Cited: 1589
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei, Alexander Ploner, K. Miriam Elfström, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 14, pp. 1340-1348
Open Access | Times Cited: 1057
Jiayao Lei, Alexander Ploner, K. Miriam Elfström, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 14, pp. 1340-1348
Open Access | Times Cited: 1057
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Marc Brisson, Jane J. Kim, Karen Canfell, et al.
The Lancet (2020) Vol. 395, Iss. 10224, pp. 575-590
Open Access | Times Cited: 664
Marc Brisson, Jane J. Kim, Karen Canfell, et al.
The Lancet (2020) Vol. 395, Iss. 10224, pp. 575-590
Open Access | Times Cited: 664
Estimates of the global burden of cervical cancer associated with HIV
Dominik Stelzle, Luana Fiengo Tanaka, Kuan Ken Lee, et al.
The Lancet Global Health (2020) Vol. 9, Iss. 2, pp. e161-e169
Open Access | Times Cited: 594
Dominik Stelzle, Luana Fiengo Tanaka, Kuan Ken Lee, et al.
The Lancet Global Health (2020) Vol. 9, Iss. 2, pp. e161-e169
Open Access | Times Cited: 594
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019
Laia Bruni, Anna Saura‐Lázaro, Alexandra Montoliu, et al.
Preventive Medicine (2020) Vol. 144, pp. 106399-106399
Open Access | Times Cited: 530
Laia Bruni, Anna Saura‐Lázaro, Alexandra Montoliu, et al.
Preventive Medicine (2020) Vol. 144, pp. 106399-106399
Open Access | Times Cited: 530
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study
Milena Falcaro, Alejandra Castañón, B Ndlela, et al.
The Lancet (2021) Vol. 398, Iss. 10316, pp. 2084-2092
Closed Access | Times Cited: 499
Milena Falcaro, Alejandra Castañón, B Ndlela, et al.
The Lancet (2021) Vol. 398, Iss. 10316, pp. 2084-2092
Closed Access | Times Cited: 499
Cancer of the cervix uteri: 2021 update
Neerja Bhatla, Daisuke Aoki, Daya Nand Sharma, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 155, Iss. S1, pp. 28-44
Open Access | Times Cited: 367
Neerja Bhatla, Daisuke Aoki, Daya Nand Sharma, et al.
International Journal of Gynecology & Obstetrics (2021) Vol. 155, Iss. S1, pp. 28-44
Open Access | Times Cited: 367
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 274
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 274
Human papillomaviruses: diversity, infection and host interactions
Alison A. McBride
Nature Reviews Microbiology (2021) Vol. 20, Iss. 2, pp. 95-108
Closed Access | Times Cited: 261
Alison A. McBride
Nature Reviews Microbiology (2021) Vol. 20, Iss. 2, pp. 95-108
Closed Access | Times Cited: 261
Human Papillomavirus Vaccines: An Updated Review
Liqin Cheng, Yan Wang, Juan Du
Vaccines (2020) Vol. 8, Iss. 3, pp. 391-391
Open Access | Times Cited: 232
Liqin Cheng, Yan Wang, Juan Du
Vaccines (2020) Vol. 8, Iss. 3, pp. 391-391
Open Access | Times Cited: 232
Immunization agenda 2030: A global strategy to leave no one behind
Vaccine (2024) Vol. 42, pp. S5-S14
Open Access | Times Cited: 226
Vaccine (2024) Vol. 42, pp. S5-S14
Open Access | Times Cited: 226
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer
Susanne K. Kjær, Christian Dehlendorff, F. Belmonte, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 10, pp. 1329-1335
Open Access | Times Cited: 202
Susanne K. Kjær, Christian Dehlendorff, F. Belmonte, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 10, pp. 1329-1335
Open Access | Times Cited: 202
Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study
Kate T. Simms, Sharon J. B. Hanley, Megan A. Smith, et al.
The Lancet Public Health (2020) Vol. 5, Iss. 4, pp. e223-e234
Open Access | Times Cited: 182
Kate T. Simms, Sharon J. B. Hanley, Megan A. Smith, et al.
The Lancet Public Health (2020) Vol. 5, Iss. 4, pp. e223-e234
Open Access | Times Cited: 182
Cervical cancer prevention and control in women living with human immunodeficiency virus
Philip E. Castle, Mark H. Einstein, Vikrant V. Sahasrabuddhe
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 6, pp. 505-526
Open Access | Times Cited: 151
Philip E. Castle, Mark H. Einstein, Vikrant V. Sahasrabuddhe
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 6, pp. 505-526
Open Access | Times Cited: 151
Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies
Feixue Wei, Michael Gaisa, Gypsyamber D’Souza, et al.
The Lancet HIV (2021) Vol. 8, Iss. 9, pp. e531-e543
Open Access | Times Cited: 144
Feixue Wei, Michael Gaisa, Gypsyamber D’Souza, et al.
The Lancet HIV (2021) Vol. 8, Iss. 9, pp. e531-e543
Open Access | Times Cited: 144
Trends of cervical cancer at global, regional, and national level: data from the Global Burden of Disease study 2019
Xingxing Zhang, Qingle Zeng, Wenwen Cai, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 139
Xingxing Zhang, Qingle Zeng, Wenwen Cai, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 139
Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah Onono, et al.
NEJM Evidence (2022) Vol. 1, Iss. 5
Open Access | Times Cited: 139
Ruanne V. Barnabas, Elizabeth R. Brown, Maricianah Onono, et al.
NEJM Evidence (2022) Vol. 1, Iss. 5
Open Access | Times Cited: 139
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
Laia Bruni, G. Albero, Jane Rowley, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 9, pp. e1345-e1362
Open Access | Times Cited: 139
Laia Bruni, G. Albero, Jane Rowley, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 9, pp. e1345-e1362
Open Access | Times Cited: 139
Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years
Shujuan Lin, Kai Gao, Simeng Gu, et al.
Cancer (2021) Vol. 127, Iss. 21, pp. 4030-4039
Open Access | Times Cited: 131
Shujuan Lin, Kai Gao, Simeng Gu, et al.
Cancer (2021) Vol. 127, Iss. 21, pp. 4030-4039
Open Access | Times Cited: 131
Epidemiology and incidence of HPV‐related cancers of the head and neck
Benjamin R. Roman, Abraham Aragones
Journal of Surgical Oncology (2021) Vol. 124, Iss. 6, pp. 920-922
Open Access | Times Cited: 128
Benjamin R. Roman, Abraham Aragones
Journal of Surgical Oncology (2021) Vol. 124, Iss. 6, pp. 920-922
Open Access | Times Cited: 128
Human Papillomavirus Vaccines
Lauri E. Markowitz, John T. Schiller
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_4, pp. S367-S378
Open Access | Times Cited: 108
Lauri E. Markowitz, John T. Schiller
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_4, pp. S367-S378
Open Access | Times Cited: 108
Human papillomavirus vaccination and cervical cancer risk
Lisa Rahangdale, Chemtai Mungo, Siobhán O’Connor, et al.
BMJ (2022), pp. e070115-e070115
Open Access | Times Cited: 102
Lisa Rahangdale, Chemtai Mungo, Siobhán O’Connor, et al.
BMJ (2022), pp. e070115-e070115
Open Access | Times Cited: 102